We further investigated the effects of B21 antibody clone on cancer stemness and EMT by determining the level of markers associated with cancer stemness and EMT by qPCR and found that B21 antibody clone inhibited the expression of cancer stemness and EMT markers as compared to OSM-stimulated cells in OVCAR8-CisR and A2780-CisR resistant cells (Supplementary Fig. 3a, b). The gene discussed is CYTH1; the disease is cancer.